SK Chemicals approve commercialization of Xarelto generic for first time
The first generic of novel oral anticoagulant(NOAC), which is rapidly invading the warfarin prescription market, was domestically approved.
Under the Patent-Linkage system, the ‘Exclusive Sale Right’ will automatically be given to the generic for 9 months.
The domestic company which acquired ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
